Wegovy, Novo Nordisk
Ozempic-Maker Novo Nordisk Sues Pharmacies And Weight Loss Clinics For Allegedly Selling Impure Drugs
N ovo Nordisk has filed nine lawsuits against medical spas, wellness clinics and pharmacies for allegedly selling impure products claiming to contain semaglutide, the active ingredient in its weight loss and diabetes drugs Wegovy and Ozempic, the latest legal dispute between the Danish drugmaker and companies that claim to sell semaglutide.
Ozempic Maker Novo Nordisk Stock Up More Than 31% In 2024, But Is It Too Late To Buy Shares?
Novo Nordisk stock traded close to a buy point Friday afternoon as shares bounced from their 21-day line this week.
Novo Nordisk blames middlemen in U.S. healthcare system for high prices of weight loss drugs Wegovy and Ozempic
In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugs
Novo Nordisk said on Thursday it had sued nine more medical spas, wellness clinics and pharmacies in the U.S. for selling products claiming to contain semaglutide, the key ingredient in its popular weight-loss drug Wegovy.
India May Have To Wait Longer For Novo Nordisk’s Weight-Loss Drug Wegovy
Indians may have to wait a while yet for Danish drug maker Novo Nordisk's blockbuster weight loss drug Wegovy, which is not expected to hit the market this year. Wegovy, a relatively new drug approved by the US Food and Drug Administration (FDA) in June 2021,
Another Ozempic user explains weight-loss drugs' growing popularity
As weight-loss drugs such as Novo Nordisk's Ozempic become more accessible, people are sharing their experiences.
Millions of Americans need drugs like Ozempic: Will it bankrupt the health care system?
An April 24 letter from Vermont Sen. Bernie Sanders to the CEO of Novo Nordisk began with heartfelt thanks to the Danish ...
Ozempic and Wegovy could double as kidney disease treatment, study suggests
Semaglutide medications including Ozempic and Wegovy have been shown to reduce kidney failure risk and the risk of death ...
Denmark Asks Doctors to Move Ozempic Patients to Cheaper Drugs
In Novo Nordisk A/S’s home country of Denmark, authorities now ask doctors to start moving Ozempic patients on to cheaper ...
Becker's Hospital Review1d
Novo Nordisk races to boost Ozempic, Wegovy production
Novo Nordisk races against time and high demand to increase supply of Ozempic and Wegovy. There are only two places in the world where semaglutide is made.
Novo Nordisk: Considerable Growth Beyond Ozempic
Novo Nordisk has a long-term growth strategy, focusing on the development of new treatments for cardiovascular diseases. Read ...
Where Will Novo Nordisk Be in 10 Years?
Novo Nordisk ( NVO 0.35%) has been a fantastic, market-beating stock to own for the past decade. Its 10-year return is an ...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Novo Nordisk's Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes and lowered the risk of ...
Becker's Hospital Review3d
Novo Nordisk defends $1,000 Ozempic list price
Novo Nordisk is contesting Sen. Bernie Sanders' calls to reduce the list prices of Ozempic and Wegovy in the U.S., Bloomberg reports.